Open label, randomized, crossover pilot trial of high‐resolution, relational, resonance‐based, electroencephalic mirroring to relieve insomnia

Effective noninvasive interventions for insomnia are needed. High‐resolution, relational, resonance‐based, electroencephalic mirroring (HIRREM™) is a noninvasive, electroencephalography (EEG)‐based method to facilitate greater client‐unique, autocalibrated improvements of balance and harmony in cort...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain and behavior 2012-11, Vol.2 (6), p.814-824
Hauptverfasser: Tegeler, Charles H., Kumar, Sandhya R., Conklin, Dave, Lee, Sung W., Gerdes, Lee, Turner, Dana P., Tegeler, Catherine L., C. Fidali, Brian, Houle, Tim T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Effective noninvasive interventions for insomnia are needed. High‐resolution, relational, resonance‐based, electroencephalic mirroring (HIRREM™) is a noninvasive, electroencephalography (EEG)‐based method to facilitate greater client‐unique, autocalibrated improvements of balance and harmony in cortical neural oscillations. This study explores using HIRREM for insomnia. Twenty subjects, with an Insomnia Severity Index (ISI) score of ≥15 (14 women, mean age 45.4, mean ISI 18.6), were enrolled in this randomized, unblinded, wait‐list control, crossover, superiority study. Subjects were randomized to receive 8–12 HIRREM sessions over 3 weeks, plus usual care (HUC), or usual care alone (UC). Pre‐ and post‐HIRREM data collection included ISI (primary outcome), and many secondary, exploratory measures (CES‐D, SF‐36, HR, BP, neurocognitive testing, and VAS scales). The UC group later crossed over to receive HIRREM. ISI was also repeated 4–6 weeks post‐HIRREM. All subjects completed the primary intervention period. Analysis for differential change of ISI in the initial intervention period for HUC versus UC showed a drop of 10.3 points (95% CI: −13.7 to −6.9, P  4 weeks post‐HIRREM. Differential change in the HUC group was also statistically significant for CES‐D (−8.8, 95% CI: −17.5 to −0.1, P = 0.047), but other exploratory outcomes were not statistically significant. For all receiving HIRREM (n = 19), decreased high‐frequency total power was seen in the bilateral temporal lobes. No adverse events were seen. This pilot clinical trial, the first using HIRREM as an intervention, suggests that HIRREM is feasible and effective for individuals having moderate‐to‐severe insomnia, with clinically relevant, statistically significant benefits based on differential change in the ISI. Effects persisted for 4 weeks after completion of HIRREM. Larger controlled clinical trials are warranted. This was a randomized, unblinded, wait‐list, cross over study of HIRREM plus usual care (HUC) versus usual care alone (UC), for subjects with insomnia, with a primary outcome of pre‐ to post‐HIRREM Insomnia Severity Index (ISI) scores. Results for differential change in ISI: −10.3 (95% CI: −13.7 to −6.9), P  4 we
ISSN:2162-3279
2162-3279
DOI:10.1002/brb3.101